Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers

Inclusion Criteria: * Healthy male aged 20 to 45 years at the screening * Subject who is over 50kg with BMI between 18 kg/m2 to 29 kg/m2 (inclusive) * Subject who fully understood after being informed detailed description of clinical trial, written informed consent voluntarily to observe the precautions. Exclusion Criteria: * Subject who has a medical history of severe cardiovascular, respiratory, hepatobiliary, renal disease hematologic, gastrointestinal, endocrinological, immunologic, dermatosis or neuropsychologic disease. * Subject who have symptoms, result from acute disease within 28days before first administration. * Subject who have chronic persisting disease with clinical significance. * Subject who fall under the criteria below in laboratory test. * AST/ALT \> UNL (upper normal limit) x 2 * Total bilirubin \> UNL x 1.5 * In case of renal failure that creatine clearance is less than 50mL/min according to Cockcroft-Gault * CPK \> UNL x 2.5 * Subject who with low blood pressure with clinical significance at screening test. (systolic blood pressure is less than 90 mmHg and diastolic blood pressure is less than 60 mmHg) * Subject with any positive reaction in HBs Ag, anti-HCV Ab, anti-HIV Ab, VDRL tests.